Literature DB >> 4018162

Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin.

R Landgraf.   

Abstract

Plasma oxytocin was determined by RIA in three male subjects under basal conditions and following administration of synthetic oxytocin. As compared to basal levels (below 10 pg/ml), plasma oxytocin was found to be elevated markedly (36 to 85 pg/ml) in response to application by nasal spray (total dose: 65 to 100 micrograms). Intramuscular injection (25 micrograms) resulted in very high oxytocin levels (360 to 480 pg/ml), whereas buccal administration (70 micrograms) was proved to be ineffective (levels below 10 pg/ml plasma). In each case, plasma vasopressin remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018162     DOI: 10.1055/s-0029-1210444

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  11 in total

1.  First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma.

Authors:  Anika Hoffmann; Jale Özyurt; Kristin Lohle; Julia Reichel; Christiane M Thiel; Hermann L Müller
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

2.  Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.

Authors:  M Ludwig; V A Tobin; M F Callahan; E Papadaki; A Becker; M Engelmann; G Leng
Journal:  J Neuroendocrinol       Date:  2013-07       Impact factor: 3.627

3.  Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.

Authors:  Meera E Modi; Fawn Connor-Stroud; Rainer Landgraf; Larry J Young; Lisa A Parr
Journal:  Psychoneuroendocrinology       Date:  2014-03-03       Impact factor: 4.905

4.  Protocol for an experimental investigation of the roles of oxytocin and social support in neuroendocrine, cardiovascular, and subjective responses to stress across age and gender.

Authors:  Laura D Kubzansky; Wendy B Mendes; Allison Appleton; Jason Block; Gail K Adler
Journal:  BMC Public Health       Date:  2009-12-21       Impact factor: 3.295

Review 5.  Temporal Dynamics of Intranasal Oxytocin in Human Brain Electrophysiology.

Authors:  Marie Zelenina; Maciej Kosilo; Janir da Cruz; Marília Antunes; Patrícia Figueiredo; Mitul A Mehta; Diana Prata
Journal:  Cereb Cortex       Date:  2022-07-12       Impact factor: 4.861

6.  Intranasal adminsitration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study.

Authors:  Andrea Clarici; Sandra Pellizzoni; Secondo Guaschino; Salvatore Alberico; Stefano Bembich; Rosella Giuliani; Antonia Short; Giuseppina Guarino; Jaak Panksepp
Journal:  Front Psychol       Date:  2015-04-20

7.  Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.

Authors:  Nadine Striepens; Keith M Kendrick; Vanessa Hanking; Rainer Landgraf; Ullrich Wüllner; Wolfgang Maier; René Hurlemann
Journal:  Sci Rep       Date:  2013-12-06       Impact factor: 4.379

8.  Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs.

Authors:  Andrea Temesi; Julianna Thuróczy; Lajos Balogh; Ádám Miklósi
Journal:  Front Vet Sci       Date:  2017-09-05

9.  Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats.

Authors:  Craig F Ferris; Jason R Yee; William M Kenkel; Kelly Marie Dumais; Kelsey Moore; Alexa H Veenema; Praveen Kulkarni; Allison M Perkybile; C Sue Carter
Journal:  Front Behav Neurosci       Date:  2015-09-17       Impact factor: 3.558

Review 10.  Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers.

Authors:  G Leng; N Sabatier
Journal:  J Neuroendocrinol       Date:  2016-10       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.